Headache: The Journal of Head and Face Pain最新文献

英文中文

Interictal Hyperperfusion in the Higher Visual Cortex in Patients With Episodic Migraine 发作性偏头痛患者的高级视觉皮层间期高灌注

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13646

L. Michels, Jeanette Villanueva, R. O'Gorman, M. Muthuraman, N. Koirala, Roman P. Büchler, A. Gantenbein, P. Sandor, R. Luechinger, S. Kollias, F. Riederer

Migraine pathophysiology is complex and probably involves cortical and subcortical alterations. Structural and functional brain imaging studies indicate alterations in the higher order visual cortex in patients with migraine. Arterial spin labeling magnetic resonance imaging (ASL‐MRI) is a non‐invasive imaging method for assessing changes in cerebral blood flow (CBF) in vivo.

偏头痛的病理生理是复杂的，可能涉及皮层和皮层下的改变。结构和功能脑成像研究表明偏头痛患者的高阶视觉皮层发生改变。动脉自旋标记磁共振成像(ASL‐MRI)是一种评估体内脑血流量(CBF)变化的非侵入性成像方法。

引用次数: 19

Pediatric Migraine Action Plan (PedMAP) 儿童偏头痛行动计划(PedMAP)

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13681

Scott B Turner, Elizabeth K. Rende, Tara Pezzuto, S. Weaver, Annmarie Henderlong-Kropp, Kaitlin A. Greene, A. Bicknese, Jennifer J. Dilts, Jessica Gautreaux, M. Victorio, L. Strauss, A. Lagman-Bartolome, Christina L. Szperka, M. Yonker, A. Hershey, A. Gelfand

引用次数: 8

What is Currently the Best Investigational Approach to the Patient With Sudden‐Onset Severe Headache? 目前对突发性严重头痛患者的最佳研究方法是什么?

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13650

A. Sjulstad, K. Alstadhaug

Presentation of Case – Ane Skaare Sjulstad, MD, Adult Neurology Resident, Nordland Hospital, Bodø, Norway A 48-year-old man with no previous medical history suddenly experienced severe intense retro-bulbar pain of pulsating character on the right side, and was seen in the emergency department 7 hours later. He was then alert and oriented, but in excruciating pain. There was no neck stiffness and no fever. The blood pressure was 141/80 mm Hg, and the pulse regular with a frequency of 48. Neurological examination was normal. Query by Dr. Sjulstad: When does actually sudden-onset severe headache represent a potential life-threatening condition? Response by Dr. Alstadhaug: There is no definite answer to that question. Atypical presentation of subarachnoid hemorrhage (SAH) with mild, or slowly progressive headache over minutes, and even absence of headache may occur in up to 3.8% of patients as reported in a recent Japanese study, but previously up to 10% has been reported. In a case series with 42 patients who had bled from an aneurysm, the headache came instantly in 50%, after 2-60 seconds in 24%, and within 1-5 minutes in 19%. In 10%-40% of patients with diagnosed bleeding from an aneurysm, there has been an episode with hyperacute headache prior to the one that led to the diagnosis. Such a warning leak has typically been reported to occur a couple of weeks earlier, but the risk of re-bleeding after SAH is highest within the first 24 hours. Non-ruptured aneurysms may also cause headache (dissection in the aneurysm wall, acute expansion or thrombosis), but more often they cause focal symptoms/signs due to mass effect Headache © 2019 The Authors. Headache: The Journal of Head and Face Pain doi: 10.1111/head.13650 published by Wiley Periodicals, Inc. on behalf of American Headache Society Published by Wiley Periodicals, Inc. ISSN 0017-8748

病例描述:Ane Skaare Sjulstad，医学博士，挪威Bodø Nordland医院成人神经内科住院医师。一名48岁男性，既往无病史，突然出现右侧剧烈的球后搏动性疼痛，7小时后到急诊科就诊。他当时神志清醒，神志清醒，但极度痛苦。没有颈部僵硬，也没有发烧。血压141/80 mm Hg，脉搏规律，频率48。神经系统检查正常。Sjulstad博士的问题:什么时候突然发作的严重头痛会成为潜在的危及生命的疾病?阿尔斯塔豪格博士的回答:这个问题没有明确的答案。据日本最近的一项研究报道，不典型表现为蛛网膜下腔出血(SAH)，伴有轻度或缓慢进行性头痛，持续数分钟，甚至没有头痛，可能发生在高达3.8%的患者中，但之前报道的发生率高达10%。在42例因动脉瘤出血的患者中，50%的人立即头痛，24%的人在2-60秒后头痛，19%的人在1-5分钟内头痛。在确诊为动脉瘤出血的患者中，有10%-40%的患者在确诊前曾有过超急性头痛发作。这种警告性渗漏通常发生在几周前，但SAH后再出血的风险在最初24小时内最高。未破裂动脉瘤也可能引起头痛(动脉瘤壁夹层、急性扩张或血栓形成)，但更常见的是由于质量效应引起局灶性症状/体征头痛©2019作者。头痛:头部和面部疼痛杂志doi: 10.1111/ Head。13650由Wiley期刊公司代表美国头痛协会出版，由Wiley期刊公司出版ISSN 0017 - 8748

{"title":"What is Currently the Best Investigational Approach to the Patient With Sudden‐Onset Severe Headache?","authors":"A. Sjulstad, K. Alstadhaug","doi":"10.1111/head.13650","DOIUrl":"https://doi.org/10.1111/head.13650","url":null,"abstract":"Presentation of Case – Ane Skaare Sjulstad, MD, Adult Neurology Resident, Nordland Hospital, Bodø, Norway A 48-year-old man with no previous medical history suddenly experienced severe intense retro-bulbar pain of pulsating character on the right side, and was seen in the emergency department 7 hours later. He was then alert and oriented, but in excruciating pain. There was no neck stiffness and no fever. The blood pressure was 141/80 mm Hg, and the pulse regular with a frequency of 48. Neurological examination was normal. Query by Dr. Sjulstad: When does actually sudden-onset severe headache represent a potential life-threatening condition? Response by Dr. Alstadhaug: There is no definite answer to that question. Atypical presentation of subarachnoid hemorrhage (SAH) with mild, or slowly progressive headache over minutes, and even absence of headache may occur in up to 3.8% of patients as reported in a recent Japanese study, but previously up to 10% has been reported. In a case series with 42 patients who had bled from an aneurysm, the headache came instantly in 50%, after 2-60 seconds in 24%, and within 1-5 minutes in 19%. In 10%-40% of patients with diagnosed bleeding from an aneurysm, there has been an episode with hyperacute headache prior to the one that led to the diagnosis. Such a warning leak has typically been reported to occur a couple of weeks earlier, but the risk of re-bleeding after SAH is highest within the first 24 hours. Non-ruptured aneurysms may also cause headache (dissection in the aneurysm wall, acute expansion or thrombosis), but more often they cause focal symptoms/signs due to mass effect Headache © 2019 The Authors. Headache: The Journal of Head and Face Pain doi: 10.1111/head.13650 published by Wiley Periodicals, Inc. on behalf of American Headache Society Published by Wiley Periodicals, Inc. ISSN 0017-8748","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85018666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine Fremanezumab预防慢性偏头痛的早期疗效

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13654

P. Winner, Egilius L H Spierings, P. Yeung, E. Aycardi, Tricia Blankenbiller, M. Grozinski-Wolff, Ronghua Yang, Yuju Ma

To assess the onset of efficacy for fremanezumab in chronic migraine by evaluating pain‐related clinical measures at different time points.

通过评估不同时间点的疼痛相关临床指标来评估fremanezumab治疗慢性偏头痛的疗效。

引用次数: 34

New Editorial Appointment 新的编辑任命

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13694

Jason Roberts

引用次数: 0

Intravenous Magnesium Sulfate to Treat Acute Headaches in the Emergency Department: A Systematic Review 静脉注射硫酸镁治疗急诊科急性头痛:系统综述

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13648

Andrew C. Miller, Brandon K Pfeffer, Michael R Lawson, K. Sewell, Alexandra R King, S. Zehtabchi

Non‐traumatic headaches comprise up to 4% of all emergency department (ED) visits. Current practice is moving toward multimodal analgesia regimens that limit narcotic use.

非创伤性头痛占所有急诊科(ED)就诊的4%。目前的做法是向多模式镇痛方案，限制麻醉的使用。

引用次数: 15

The Development of the Pediatric Migraine Action Plan (PedMAP) 儿童偏头痛行动计划(PedMAP)的制定

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13666

Scott B Turner, Elizabeth K. Rende, Christina L. Szperka, A. Hershey, A. Gelfand

引用次数: 3

Dramatic Response to Nebivolol in an Adult Case of Cyclic Vomiting Syndrome 奈比洛尔治疗一例成人周期性呕吐综合征的显著反应

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13619

S. Redon, A. Donnet

Cyclic vomiting syndrome (CVS) is an episodic syndrome associated with migraine, characterized by stereotypical attacks of intense nausea and vomiting, recurring with a predictable periodicity. Preventive treatment should be considered if attacks are frequent and refractory to attack treatment. Retrospective studies showed benefit using tricyclic antidepressants, antiepileptics (zonisamide, levetiracetam, topiramate), or β-blockers (propranolol). In adult, no controlled trials are available. A case report showed efficacy of nebivolol in addition to amitriptyline in an 18-year-old girl with CVS. We report for the first time a near-resolution of adult CVS with nebivolol in monotherapy. A 58-year-old woman with a history of thyroid carcinoma and hepatic metastasis treated 10 years ago reported episodes of intense nausea and vomiting, from the age of 40. She had no personal history of migraine but her brother had migraine. The attacks were stereotypical, with a predictable periodicity, from 6 months during the first years to 1 month for the last 3 years. Without any apparent reason, the episodes were more frequent in the months previous her admission at headache center (2 attacks per month). The attacks began during sleep at night, typically on the weekend, with a mean duration of 48 hours. During prodromal phase (previous day), she reported intense tiredness. Concentration difficulties, photophobia and vertigo were also reported during emetic phase. No headache was reported. The resolution was complete between episodes. A brain MRI was normal. Digestive investigations (abdominal computed tomography scan, upper gastrointestinal endoscopy, colonoscopy) didn’t show any lesion responsible for CVS. The high intensity of vomiting was responsible for multiple hospitalizations with intravenous hydration. Antiemetics or sumatriptan were ineffective as attack treatment. An association with Amitriptyline (5 mg/day), coenzyme Q10 and L-carnitine during 2 months was not effective on attack frequency. Higher dosage of amitriptyline was not tolerated. Propranolol (10 mg/day) was tried during 6 weeks but was not tolerated. Two CVS attacks Headache doi: 10.1111/head.13619 © 2019 American Headache Society Published by Wiley Periodicals, Inc. ISSN 0017-8748

周期性呕吐综合征(CVS)是一种与偏头痛相关的发作性综合征，以典型的强烈恶心和呕吐为特征，以可预测的周期性复发。如果发作频繁且发作治疗难治性，应考虑预防性治疗。回顾性研究表明，使用三环抗抑郁药、抗癫痫药(唑尼沙胺、左乙拉西坦、托吡酯)或β受体阻滞剂(心得安)是有益的。在成人中，没有对照试验。一份病例报告显示奈比洛尔和阿米替林对一名18岁的CVS女孩有效。我们首次报道了奈比沃罗单药治疗成人CVS的接近解决。一名58岁女性，10年前曾接受甲状腺癌和肝转移治疗，自40岁起出现强烈恶心和呕吐。她没有偏头痛的个人病史，但她的兄弟有偏头痛。这些攻击是典型的，具有可预测的周期性，从头几年的6个月到后三年的1个月。无明显原因，在入院前数月发作更为频繁(每月2次)。发作开始于夜间睡眠，通常在周末，平均持续时间为48小时。在前驱期(前一天)，她报告了强烈的疲劳。呕吐期还出现注意力集中困难、畏光和眩晕。无头痛报告。两集之间的解决是完全的。脑部核磁共振检查正常。消化道检查(腹部计算机断层扫描、上消化道内窥镜检查、结肠镜检查)未发现任何引起CVS的病变。高强度呕吐是多次静脉补水住院的原因。止吐药或舒马匹坦作为发作治疗无效。阿米替林(5mg /天)、辅酶Q10和左旋肉碱联合用药2个月对发作频率无效。更高剂量的阿米替林不耐受。普萘洛尔(10 mg/天)试验6周，但不耐受。两个CVS攻击头痛doi: 10.1111/head。13619©2019美国头痛协会由Wiley期刊公司出版。ISSN 0017 - 8748

{"title":"Dramatic Response to Nebivolol in an Adult Case of Cyclic Vomiting Syndrome","authors":"S. Redon, A. Donnet","doi":"10.1111/head.13619","DOIUrl":"https://doi.org/10.1111/head.13619","url":null,"abstract":"Cyclic vomiting syndrome (CVS) is an episodic syndrome associated with migraine, characterized by stereotypical attacks of intense nausea and vomiting, recurring with a predictable periodicity. Preventive treatment should be considered if attacks are frequent and refractory to attack treatment. Retrospective studies showed benefit using tricyclic antidepressants, antiepileptics (zonisamide, levetiracetam, topiramate), or β-blockers (propranolol). In adult, no controlled trials are available. A case report showed efficacy of nebivolol in addition to amitriptyline in an 18-year-old girl with CVS. We report for the first time a near-resolution of adult CVS with nebivolol in monotherapy. A 58-year-old woman with a history of thyroid carcinoma and hepatic metastasis treated 10 years ago reported episodes of intense nausea and vomiting, from the age of 40. She had no personal history of migraine but her brother had migraine. The attacks were stereotypical, with a predictable periodicity, from 6 months during the first years to 1 month for the last 3 years. Without any apparent reason, the episodes were more frequent in the months previous her admission at headache center (2 attacks per month). The attacks began during sleep at night, typically on the weekend, with a mean duration of 48 hours. During prodromal phase (previous day), she reported intense tiredness. Concentration difficulties, photophobia and vertigo were also reported during emetic phase. No headache was reported. The resolution was complete between episodes. A brain MRI was normal. Digestive investigations (abdominal computed tomography scan, upper gastrointestinal endoscopy, colonoscopy) didn’t show any lesion responsible for CVS. The high intensity of vomiting was responsible for multiple hospitalizations with intravenous hydration. Antiemetics or sumatriptan were ineffective as attack treatment. An association with Amitriptyline (5 mg/day), coenzyme Q10 and L-carnitine during 2 months was not effective on attack frequency. Higher dosage of amitriptyline was not tolerated. Propranolol (10 mg/day) was tried during 6 weeks but was not tolerated. Two CVS attacks Headache doi: 10.1111/head.13619 © 2019 American Headache Society Published by Wiley Periodicals, Inc. ISSN 0017-8748","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"55 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83858069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Differences of Cluster Headache on the Basis of Sex in the Korean Cluster Headache Registry 韩国集束性头痛登记中基于性别的集束性头痛差异

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13637

P. Chung, Mi Ji Lee, Jeong-Wook Park, J. Sohn, Byung-Kun Kim, M. Chu, Jae-Myun Chung, Jin-Young Ahn, Yun-Ju Choi, Soo-Kyoung Kim, D. Bae, Daeyoung Kim, H. Moon, C. Chung, Soo-Jin Cho

Most of the clinical characteristics of cluster headache (CH) have been established through the observation of men with CH. Epidemiological data of CH in women are scarce especially in the Asian population. Here, we sought to assess the prevalence and clinical characteristics of women with CH in comparison to men in a prospective CH registry.

丛集性头痛的大部分临床特征是通过对男性丛集性头痛患者的观察确定的。女性丛集性头痛的流行病学资料很少，特别是在亚洲人群中。在这里，我们试图在前瞻性CH登记中评估女性CH的患病率和临床特征，并与男性进行比较。

引用次数: 13

Cognitive Biases & Errors in Headache Medicine 头痛医学中的认知偏差与错误

Headache: The Journal of Head and Face Pain

Pub Date : 2019-11-01 DOI: 10.1111/head.13686

Christopher H Gottschalk

In recent years, the importance and prevalence of cognitive biases has gained scholarly attention in medicine as well as management science regarding a wide range of human activities.

近年来，认知偏差的重要性和普遍性在医学和管理科学中引起了广泛的学术关注。

引用次数: 2

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Headache: The Journal of Head and Face Pain

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀